Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling. | J Adv Res | 2023 | 35973552 | PubTator, text mining | PubMed |
| Cardiovascular Toxicities with Chimeric Antigen Receptor T-cell Therapy. | Curr Cardiol Rev | 2023 | 35747980 | PubTator, text mining | PubMed |
| Extracellular vesicles and lipoproteins - Smart messengers of blood cells in the circulation. | J Extracell Biol | 2022 | 38938581 | PubTator, text mining | PubMed |
| Cancer testis antigen PASD1 expression and immunogenicity in human colorectal cancer and polyps. | Turk J Biol | 2022 | 37529004 | PubTator, text mining | PubMed |
| Peptide emulsions in incomplete Freund's adjuvant create effective nurseries promoting egress of systemic CD4+ and CD8+ T cells for immunotherapy of cancer. | J Immunother Cancer | 2022 | 36939214 | PubTator, text mining | PubMed |
| Increased response to TPF chemotherapy promotes immune escape in hypopharyngeal squamous cell carcinoma. | Front Pharmacol | 2022 | 36712687 | PubTator, text mining | PubMed |
| Epigenetic modifications in esophageal cancer: An evolving biomarker. | Front Genet | 2022 | 36704345 | PubTator, text mining | PubMed |
| Extracellular vesicles and melanoma: New perspectives on tumor microenvironment and metastasis. | Front Cell Dev Biol | 2022 | 36704194 | PubTator, text mining | PubMed |
| Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma. | J Pers Med | 2022 | 36675674 | PubTator, text mining | PubMed |
| Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patients. | Ann Transl Med | 2022 | 36660727 | PubTator, text mining | PubMed |
| Advances in adoptive cellular therapy for colorectal cancer: a narrative review. | Ann Transl Med | 2022 | 36660664 | PubTator, text mining | PubMed |
| Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises. | Explor Target Antitumor Ther | 2022 | 36654823 | PubTator, text mining | PubMed |
| Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer. | JACC CardioOncol | 2022 | 36636447 | PubTator, text mining | PubMed |
| Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2022 | 36636439 | PubTator, text mining | PubMed |
| Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation. | Front Immunol | 2022 | 36618423 | PubTator, text mining | PubMed |
| Cutaneous Melanoma and Hormones: Focus on Sex Differences and the Testis. | Int J Mol Sci | 2022 | 36614041 | PubTator, text mining | PubMed |
| Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment. | Cancers (Basel) | 2022 | 36612077 | PubTator, text mining | PubMed |
| The Convergence of FTIR and EVs: Emergence Strategy for Non-Invasive Cancer Markers Discovery. | Diagnostics (Basel) | 2022 | 36611313 | PubTator, text mining | PubMed |
| Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells. | J Immunother Cancer | 2022 | 36600602 | PubTator, text mining | PubMed |
| Current status and challenges of immunotherapy in ALK rearranged NSCLC. | Front Oncol | 2022 | 36591504 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=18